TSX:BHC (Bausch Health Companies Inc.)

About BHC

Bausch Health Companies Inc. is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries. Five pillars or guiding principles represent the foundation on which we are realizing our mission as an organization: People Quality Health Care Outcomes Customer Focus Innovation and Efficiency.
  • Bausch Health Companies Inc. (TSX: BHC) Latest News

    The Motley Fool
    Top TSX Stocks

    Top Stock Picks for February

    We asked our contributors to pick their favorite Canadian stocks to buy this month. Here are their top ideas.

    Read more »

    The Motley Fool
    Investing

    2 Amazing Turnarounds, Plus One to Watch

    Warren Buffett famously avoids turnarounds, but you may want to consider these.

    Read more »

    Investing

    S&P/TSX Flat in Light Trading, Poised to Underperform U.S. by 17%

    Money managers were window dressing their portfolios before year-end

    Read more »

    The Motley Fool
    Investing

    S&P/TSX Higher As Investors Await Fed’s Tapering Plans

    Disclosure: Robert Baillieul has no positions in any of the stocks mentioned in this article.

    Read more »

    The Motley Fool
    Investing

    5 Barely Profitable Companies Priced to Sell

    Be mindful of relative expectations before wading into this collection of names.

    Read more »

    The Motley Fool
    Investing

    Take Stock – 2013 Year in Review (So Far) and Stocks to Watch for the Second Half

    This week's edition is here! Check it out!

    Read more »

    The Motley Fool
    Investing

    Canadian Stocks Fall, led by Valeant Pharmaceuticals

    The TSX starts the week in the red.

    Read more »

    The Motley Fool
    Investing

    The CFO’s Buying – Are You?

    An academic study indicates there's one insider who's actions mean more than the others.

    Read more »

    The Motley Fool
    Investing

    Canadian Stocks Going for a Memorial Day Run

    Closed U.S. markets haven't stopped these three names from surging higher.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Shares Jump on Rumoured Deal

    This company is going to pull off a massive deal one way or the other.

    Read more »

    The Motley Fool
    Investing

    Royal Bank of Canada Powers the TSX Higher

    Gold, oil down, Canada's market up. Huh?

    Read more »

    The Motley Fool
    Investing

    Valeant, Capstone Higher But For Opposite Reasons

    One company is a serial acquirer that faces a busted deal. The other just transformed the company in one fell…

    Read more »